Beyond CRBN and VHL
Protein degrader with scientific revolution
개발 파이프라인VIEW MORE
NEWS / 공시정보VIEW MORE
[News] 핀테라퓨틱스 “단백질분해신약, 2024년까지 美 임상 진입”
[Conference Talk] 5th Annual Targeted Protein Degradation Summit 2022, Speaker Hyunsun Jo on "Target Protein Selectivity and Safety of CRBN Mediated Molecular Glue Degrader"
[Conference Talk] Protein Degradation & Targeting Undruggables Europe 2022, Speaker Hyunsun Jo on "Molecular Glue Identification Using the E3 Ligase Binder"
[New Hire Announcement] Welcome Firoz Jaipuri to Pin Therapeutics as a Director of Platform Chemistry